BioCardia, Inc.·4

Jul 2, 9:03 PM ET

McClung David 4

4 · BioCardia, Inc. · Filed Jul 2, 2025

Insider Transaction Report

Form 4
Period: 2025-06-30
McClung David
Chief Financial Officer
Transactions
  • Purchase

    Warrant (right to buy)

    2025-06-30+4,81926,275 total
    Exercise: $1.95From: 2025-06-30Exp: 2030-06-30Common Stock (4,819 underlying)
  • Purchase

    Common Stock

    2025-06-30$2.08/sh+4,819$9,99947,950 total
Footnotes (1)
  • [F1]On June 30, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4